Lung cancer diagnosis from proteomic analysis of preinvasive lesions

Cancer Research

Volumn 71, Issue 8, 2011, Pages 3009-3017

  Rahman, S M Jamshedur ^a   Gonzalez, Adriana L ^b   Li, Ming ^d   Seeley, Erin H ^b,c   Zimmerman, Lisa J ^b   Zhang, Xueqiong J ^d   Manier, M Lisa ^a,b,c   Olson, Sandra J ^b   Shah, Ronak N ^a   Miller, Alison N ^a,h   Putnam, Joe B ^b   Miller, York E ⁱ   Franklin, Wilbur A ^j   Blot, William J ^f   Carbone, David P ^b,c,e,g   Shyr, Yu ^d   Caprioli, Richard M ^b,c   Massion, Pierre P ^a,g,h  

^a VANDERBILT UNIVERSITY   (United States)

^b Department of Pathology ^*  (United States)

^c Mass Spectrometry Research Center   (United States)

^d Department of Biostatistics   (United States)

^e Department of Medicine   (United States)

^f Department of Medicine   (United States)

^g VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ Pulmonary Division   (United States)

^j UNIVERSITY OF COLORADO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRONCHUS; CANCER DIAGNOSIS; CARCINOMA IN SITU; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL MODEL; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 79954618053     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-2510     Document Type: Article

References (42)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. Epub 2011 Feb 4.
2. Marshall E. Cancer screening. The promise and pitfalls of a cancer breakthrough. Science 2010;330:900-1.
3. Franklin WA, Gazdar AF, Haney J, Wistuba II, La Rosa FG, Kennedy T, et al. Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J Clin Invest 1997; 100:2133-7. (Pubitemid 27459370)
4. Spira A, Beane JE, Shah V, Steiling K, Liu G, Schembri F, et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 2007;13:361-6. (Pubitemid 46376687)
5. Kennedy TC, McWilliams A, Edell E, Sutedja T, Downie G, Yung R, et al. Bronchial intraepithelial neoplasia/early central airways lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:221S-33S. (Pubitemid 47502809)
6. Bota S, Auliac JB, Paris C, Metayer J, Sesboue R, Nouvet G, et al. Follow-up of bronchial precancerous lesions and carcinoma in situ using fluorescence endoscopy. Am J Respir Crit Care Med 2001; 164:1688-93. (Pubitemid 33124160)
7. Miller YE, Blatchford P, Hyun DS, Keith RL, Kennedy TC, Wolf H, et al. Bronchial epithelial Ki-67 index is related to histology, smoking, and gender, but not lung cancer or chronic obstructive pulmonary disease. Cancer Epidemiol Biomarkers Prev 2007;16:2425-31. (Pubitemid 351196376)
8. Paris C, Benichou J, Bota S, Sagnier S, Metayer J, Eloy S, et al. Occupational and nonoccupational factors associated with high grade bronchial pre-invasive lesions. Eur Respir J 2003;21:332-41. (Pubitemid 36204551)
9. Keith RL, Miller YE, Gemmill RM, Drabkin HA, Dempsey EC, Kennedy TC, et al. Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer. Clin Cancer Res 2000;6:1616-25. (Pubitemid 30305052)
10. Banerjee AK. Preinvasive lesions of the bronchus. J Thorac Oncol 2009;4:545-51.
11. Loewen G, Natarajan N, Tan D, Nava E, Klippenstein D, Mahoney M, et al. Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment. Thorax 2007;62:335-40. (Pubitemid 46580577)
12. McWilliams A, Mayo J, MacDonald S, leRiche JC, Palcic B, Szabo E, et al. Lung cancer screening: A different paradigm. Am J Respir Crit Care Med 2003;168:1167-73. (Pubitemid 37421833)
13. Franklin WA. Diagnosis of lung cancer: Pathology of invasive and preinvasive neoplasia. Chest 2000;117:80S-9S. (Pubitemid 30225145)
14. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y. The new World Health Organization classification of lung tumours. Eur Respir J 2001;18:1059-68. (Pubitemid 34092881)
15. Rahman SM, Shyr Y, Yildiz PB, Gonzalez AL, Li H, Zhang X, et al. Proteomic patterns of preinvasive bronchial lesions. Am J Respir Crit Care Med 2005;172:1556-62. (Pubitemid 43076545)
16. Yanagisawa K, Shyr Y, Xu BJ, Massion PP, Larsen PH, White BC, et al. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 2003;362:433-9. (Pubitemid 36999706)
17. Hirsch FR, Prindiville SA, Miller YE, Franklin WA, Dempsey EC, Murphy JR, et al. Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: A randomized study. J Natl Cancer Inst 2001;93:1385-91. (Pubitemid 32936815)
18. Aerni HR, Cornett DS, Caprioli RM. Automated acoustic matrix deposition for MALDI sample preparation. Anal Chem 2006;78: 827-34. (Pubitemid 43228590)
19. Chen S, Li M, Hong D, Billheimer D, Li H, Xu BJ, et al. A novel comprehensive wave-form MS data processing method. Bioinformatics 2009;25:808-14.
20. Shyr Y, Kim K. Weighted flexible compound covariate method for classifying microarray data. In:Berrar D, editor. A Practical Approach to Microarray Data Analysis. New York: Kluwer Academic; 2003:186-200.
21. Efron BaT R. An introduction to the Bootstrap. New York: Chapman and Hall; 1993.
22. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. The STARD statement for reporting studies of diagnostic accuracy: Explanation and elaboration. Clin Chem 2003;49:7-18. (Pubitemid 36078547)
23. Stoeckli M, Chaurand P, Hallahan DE, Caprioli RM. Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues. Nat Med 2001;7:493-6. (Pubitemid 32298555)
24. Hardesty WM. Proteomic analysis and classification of metastatic melanoma by MLADI imaging mass spectrometry. Nashville, TN: Vanderbilt University; 2010.
25. Chaurand P, Fouchecourt S, DaGue BB, Xu BJ, Reyzer ML, Orgebin- Crist MC, et al. Profiling and imaging proteins in the mouse epididymis by imaging mass spectrometry. Proteomics 2003;3:2221-39. (Pubitemid 37414087)
26. Haussinger K, Becker H, Stanzel F, Kreuzer A, Schmidt B, Strausz J, et al. Autofluorescence bronchoscopy with white light bronchoscopy compared with white light bronchoscopy alone for the detection of precancerous lesions: A European randomised controlled multicentre trial. Thorax 2005;60:496-503. (Pubitemid 40814050)
27. Auerbach O, Forman JB, Gere JB, Kassouny DY, Muehsam GE, Petrick TG, Smolin HJ, et al. Changes in the bronchial epithelium in relation to smoking and cancer of the lung: Report of progress. N Engl J Med 1957;256:97-104.
28. Cornett DS, Reyzer ML, Chaurand P, Caprioli RM. MALDI imaging mass spectrometry: Molecular snapshots of biochemical systems. Nat Methods 2007;4:828-33. (Pubitemid 350055580)
29. Neess D, Kiilerich P, Sandberg MB, Helledie T, Nielsen R, Mandrup S. ACBP-a PPAR and SREBP modulated housekeeping gene. Mol Cell Biochem 2006;284:149-57. (Pubitemid 44404422)
30. Li W, Ding F, Zhang L, Liu Z, Wu Y, Luo A, et al. Overexpression of stefin A in human esophageal squamous cell carcinoma cells inhibits tumor cell growth, angiogenesis, invasion, and metastasis. Clin Cancer Res 2005;11:8753-62. (Pubitemid 43005926)
31. Strojan P, Budihna M, Smid L, Svetic B, Vrhovec I, Kos J, et al. Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 2000;6:1052-62. (Pubitemid 30159367)
32. Leinonen T, Pirinen R, Bohm J, Johansson R, Rinne A, Weber E, et al. Biological and prognostic role of acid cysteine proteinase inhibitor (ACPI, cystatin A) in non-small-cell lung cancer. J Clin Pathol 2007;60:515-9. (Pubitemid 46867161)
33. Herring K. Identification of protein markers of drug-induced nephrotoxicity by MALDI MS: In vivo discovery of ubiquitin-T. Nashville: Vanderbilt University; 2009.
34. McClelland M, Zhao L, Carskadon S, Arenberg D. Expression of CD74, the receptor for macrophage migration inhibitory factor, in non-small cell lung cancer. Am J Pathol 2009;174:638-46.
35. Campa MJ, Wang MZ, Howard B, Fitzgerald MC, Patz EF Jr. Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer. Cancer Res 2003;63:1652-6. (Pubitemid 36373658)
36. Rendon BE, Roger T, Teneng I, Zhao M, Al-Abed Y, Calandra T, et al. Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor. J Biol Chem 2007;282:29910-8. (Pubitemid 350035289)
37. Kobayashi T, Okada F, Fujii N, Tomita N, Ito S, Tazawa H, et al. Thymosin-beta4 regulates motility and metastasis of malignant mouse fibrosarcoma cells. Am J Pathol 2002;160:869-82. (Pubitemid 34224577)
38. Cha HJ, Jeong MJ, Kleinman HK. Role of thymosin beta4 in tumor metastasis and angiogenesis. J Natl Cancer Inst 2003;95:1674-80. (Pubitemid 37509076)
39. Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider PM, et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003;22:8031-41. (Pubitemid 37175867)
40. Xu BJ, Gonzalez AL, Kikuchi T, Yanagisawa K, Massion PP, Wu H, et al. MALDI-MS derived prognostic protein markers for resected nonsmall cell lung cancer. Proteomics Clin Appl 2008;2:1508-17.
41. Nicholson AG, Perry LJ, Cury PM, Jackson P, McCormick CM, Corrin B, et al. Reproducibility of the WHO/IASLC grading system for pre-invasive squamous lesions of the bronchus: A study of inter-observer and intra-observer variation. Histopathology 2001;38:202-8. (Pubitemid 32862728)
42. Kujan O, Khattab A, Oliver RJ, Roberts SA, Thakker N, Sloan P. Why oral histopathology suffers inter-observer variability on grading oral epithelial dysplasia: An attempt to understand the sources of variation. Oral Oncol 2007;43:224-31. (Pubitemid 46228016)